Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013230
Filing Date
2022-05-13
Accepted
2022-05-13 11:49:07
Documents
45
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 729117
2 ex31-1.htm EX-31.1 9468
3 ex31-2.htm EX-31.2 9485
4 ex32-1.htm EX-32.1 4747
5 ex32-2.htm EX-32.2 4736
  Complete submission text file 0001493152-22-013230.txt   3471729

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bblg-20220331.xsd EX-101.SCH 32152
7 XBRL CALCULATION FILE bblg-20220331_cal.xml EX-101.CAL 25705
8 XBRL DEFINITION FILE bblg-20220331_def.xml EX-101.DEF 104593
9 XBRL LABEL FILE bblg-20220331_lab.xml EX-101.LAB 256908
10 XBRL PRESENTATION FILE bblg-20220331_pre.xml EX-101.PRE 174077
39 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 550473
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

EIN.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40899 | Film No.: 22921147
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies